New Delhi : Maharishi Ayurveda Products Pvt Ltd (MAPPL) today announced the launch of its franchise model, a first for any company in the healthcare sector. MAPPL combines the ancient Indian Ayurveda texts with the relevant contributions of modern Sciences. The market growth rate of herbal products exceeds that of allopathic medicines. The combined World Herbal Market in the year 2007 was over $200 billion and it is estimated to cross $5 trillion by 2050 as per a study released by WHO. As per WHO, about 80% Indians use Ayurveda. In the West, more than 60% people resort to Alternative Medicine.

Mr.Anand Shrivastava, Chairman and Managing Director, MAPPL said, ‘It is not infrequent that we read about the withdrawal symptoms of Allopathic Medicines due to adverse side-effects. With more and more people becoming aware of the side-effects of Modern Medicine, Ayurveda offers a natural and holistic healing experience from within’.

‘We at Maharishi Ayurveda envision a disease free society. Working towards it, we are looking at aggressively expanding our network through the franchise route. We have launched two models targeting Tier I, II and III cities’, added Mr. Shrivastava.

Mr.Shrivastava further added, ‘Maharishi Ayurveda has lead the way by adopting rigorous quality and safety standard for all its products. Yet again, we want to revolutionize the healthcare sector in India with the launch of our franchise model, which is a first in this sector in India’.

MAPPL began retail in 1987 with its propriety product ‘Amrit Kalash’. Today, it comprises a product range of over 1500 products covering Herbal Medicines, Rasayanas, Food Supplements, Beverages, Personal Care Items, Cosmetics etc. MAPPL has an in-house R&D facility, set-up in 1988, recognized by the Department of Science and Technology, Government of India. The R&D facility has established coop-programs and linkages with other National and International Medical Institutions & Research Centres, particularly those involved in conducting Clinical & Investigative Laboratory Test & Trials. MAPPL was uniquely selected for helping AYUSH in the exercise of defining production protocols for some serious classical Ayurveda products mandated under the Golden Triangle Project. MAPPL has adopted rigorous National & International Quality & Safety Standards, like ISO 9001-2008, HACCP, GMP, WHO GMP, Good Laboratory Mgt. Systems, Food Safety Systems , BDIH Certifications,.

MAPPL has widespread presence in over 40 countries across the globe, including U.S.A., Canada, UK, Germany, Italy, Norway, Sweden, Holland, Ireland, South Africa, Japan, Philippines, Australia, New Zealand, Mauritius, Singapore, Thailand & others through a network of Country Distributors.